Dr Moe Wehbe was a Drug Delivery Strategist at Microdermics. He specialises in preclinical drug development and has been involved in the evaluation of microneedles for vaccine, anti-cancer and anti-inflammatory indications. He earned his PhD in Pharmaceutical Sciences at the University of British Columbia under Dr Marcel Bally and Dr Helen Burt. Dr Wehbe’s research interests are in nanotechnology, pharmacokinetics and medical device development.